Evidence map›Paper›PMID 33927796›Full record

ArticleOxidative medicine and cellular longevity2021

Melatonin Alleviates the Toxicity of High Nicotinamide Concentrations in Oocytes: Potential Interaction with Nicotinamide Methylation Signaling.

Marwa El-Sheikh, Ahmed Atef Mesalam, Seok-Hwan Song, Jonghyeok Ko, Il-Keun Kong

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Effects of nicotinamide on follicular development and the quality of oocytes.Reproductive biology and endocrinology : RB&E · 2022
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Marwa El-SheikhDivision of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Republic of Korea.ORCID https://orcid.org/0000-0003-4666-3515
Ahmed Atef MesalamDivision of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Republic of Korea.ORCID https://orcid.org/0000-0003-4605-2976
Seok-Hwan SongThe King Kong Corp. Ltd., Gyeongsang National University, Jinju 52828, Republic of Korea.
Jonghyeok KoThe King Kong Corp. Ltd., Gyeongsang National University, Jinju 52828, Republic of Korea.
Il-Keun KongDivision of Applied Life Science (BK21 Four), Gyeongsang National University, Jinju 52828, Republic of Korea.ORCID https://orcid.org/0000-0001-5567-1088
Gyeongsang National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the numerous studies on melatonin and nicotinamide (NAM, the active form of vitamin B3), the linkage between these two biomolecules in the context of signaling pathways regulating preimplantation embryo development has not yet been investigated. In this study, we used bovine oocyte model to elucidate the effect of melatonin on the developmental competence of oocytes under the stress of high NAM concentrations. Results showed that NAM (20 mM) administration during in vitro maturation (IVM) significantly reduced oocyte maturation and actin distribution, while induced reactive oxygen species (ROS) accumulation and mitochondrial dysfunction, the multiple deleterious effects that were alleviated by melatonin (10

Indexed as

ApoptosisFemaleHumansMelatoninMethylationNiacinamideOocytesSignal TransductionMelatoninNiacinamide

Identifiers

PMID33927796
PMCPMC8049830
OpenAlexW3146624537

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.